A recent series by the investigative newsroom ProPublica has highlighted the high mortality rate among U.S. dialysis patients and stirred up controversy about patient safety.

Below are the ProPublica articles and some of the renal community's responses to it:

God help you. You're on dialysis
The first article in the ProPublica series highlighting the high cost and high mortality rate in the U.S. ESRD program.

When needles dislodge, dialysis can turn deadly
ProPublica continues its series on dialysis, focusing on cases of needle dislodgment during hemodialysis treatments.

In dialysis, life-saving care at great risk and cost
This provides a link to ProPublica's entire dialysis series


KCP responds to series on dialysis care
Kidney Care Partners released a statement in response to the new magazine series on dialysis.

Medicare's Barry Straube responds to ProPublica series on dialysis

Statement from Fresenius Medical Care

Statement from DaVita

Bill Peckham dissects DaVita CMO's response
Higher incidence is not a valid reason for higher mortality, the blogger and home dialyzor wrote in response to comments by Allen Nissenson, MD, in the Denver Post.